366 results on '"Assié, Guillaume"'
Search Results
2. Whole blood transcriptome signature predicts severe forms of COVID-19: Results from the COVIDeF cohort study
3. Differentiation between adrenocortical carcinoma and lipid-poor adrenal adenoma using a multiparametric MRI-based diagnostic algorithm
4. Pituitary surgery outcome in patients 75 years and older: a retrospective study
5. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) for the diagnosis of Cushing's syndrome: Genetics of Cushing's syndrome
6. DNA hypermethylation driven by DNMT1 and DNMT3A favors tumor immune escape contributing to the aggressiveness of adrenocortical carcinoma
7. Artificial intelligence in adrenal imaging: A critical review of current applications
8. Consensus statement by the French Society of Endocrinology (SFE) and French Society of Pediatric Endocrinology & Diabetology (SFEDP) on diagnosis of Cushing's syndrome
9. From Nelson's Syndrome to Corticotroph Tumor Progression Speed: An Update.
10. Positive Correlation Between 18F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas
11. TP53 mutations in functional corticotroph tumors are linked to invasion and worse clinical outcome
12. Whole blood methylome-derived features to discriminate endocrine hypertension
13. Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing’s disease
14. Prognostic Impact of Hypothalamic Perforation in Adult Patients With Craniopharyngioma: A Cohort Study.
15. Whole blood transcriptomic signature of Cushing's syndrome.
16. A computed tomography-based radiomic score to predict survival in patients with adrenocortical carcinoma
17. Carney complex predisposes to breast cancer: prospective study of 50 women
18. Comprehensive Pan-Genomic Characterization of Adrenocortical Carcinoma
19. Artificial Intelligence in Endocrinology: On Track Toward Great Opportunities.
20. THU504 Is Carney Complex A Predisposing Syndrome For Breast Cancer? Prospective Study Of 50 Women
21. FRI135 Differential Expression Of Circulating MicroRNAs In Primary Aldosteronism: Potential Biomarkers For Improved Diagnosis
22. Genetics of Adrenocortical Cancers
23. Genomic insights into Cushing syndrome
24. EZH2 cooperates with E2F1 to stimulate expression of genes involved in adrenocortical carcinoma aggressiveness
25. Embryonic stem cell factor FOXD3 (Genesis) defects in gastrointestinal stromal tumors
26. Adrenocortical Carcinoma: Genetics and Molecular Markers
27. The super-enhancer landscape reflects molecular subgroups of adrenocortical carcinoma
28. The World Health Organization classifications of pituitary neuroendocrine tumours: a clinico-pathological appraisal
29. Supplementary Table 2 from Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
30. Supplementary Table 3 from Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
31. Data from Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
32. Supplementary Table 1 from Transcriptome Analysis Reveals that p53 and β-Catenin Alterations Occur in a Group of Aggressive Adrenocortical Cancers
33. C-peptide level concomitant with hypoglycemia gives better performances than insulin for the diagnosis of endogenous hyperinsulinism: a single-center study of 159 fasting trials
34. Biological and radiological exploration and management of non-functioning pituitary adenoma
35. Efficacy of endoscopic endonasal transsphenoidal surgery for Cushing’s disease in 230 patients with positive and negative MRI
36. Revisiting the Nelson’s Syndrome: Corticotroph Tumor Progression After Bilateral Adrenalectomy in Cushing’s Disease
37. Nelson’s Syndrome: Corticotroph Tumor Progression After Bilateral Adrenalectomy in Cushing’s Disease
38. Corticotroph tumor progression speed after adrenalectomy
39. OR12-3 Identification of Predictive Criteria for the Primary Bilateral Macronodular Adrenal Hyperplasia Gene ARMC5: A European Series of 352 Unselected Patients.
40. OR04-3 Genetic Alterations of ARMC5 and KDM1A Are Associated With Different Expression Profiles of Illegitimate Receptors in Primary Bilateral Macronodular Adrenal Hyperplasia
41. Machine learning for classification of hypertension subtypes using multi-omics: A multi-centre, retrospective, data-driven study
42. 95 - Adrenal Genomics II: Familial and Sporadic Neoplasia
43. Outcome of giant pituitary tumors requiring surgery
44. Predicting Hypertension Subtypes with Machine Learning Using Targeted Metabolites and Their Ratios
45. Decreased steroidogenic enzyme activity in benign adrenocortical tumors is more pronounced in bilateral lesions as determined by steroid profiling in LC-MS/MS during ACTH stimulation test
46. Differences in the spectrum of steroidogenic enzyme inhibition between Osilodrostat and Metyrapone in ACTH-dependent Cushing syndrome patients
47. Identification of glucocorticoid-related molecular signature by whole blood methylome analysis
48. Assessment of VAV2 Expression Refines Prognostic Prediction in Adrenocortical Carcinoma
49. Positive Correlation Between 18 F-FDG Uptake and Tumor-Proliferating Antigen Ki-67 Expression in Adrenocortical Carcinomas.
50. Identification of predictive criteria for pathogenic variants of primary bilateral macronodular adrenal hyperplasia (PBMAH) gene ARMC5 in 352 unselected patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.